These derivatives have promoted the mRNA and protein level of Nrf2 and they have activated the Nrf2/ARE pathway in a transgenic adenocarcinoma mouse prostate (TRAMP) model of prostate cancer. The gene discussed is NFE2L2; the disease is Familial prostate cancer.